Sponsor

University of Cologne

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of Cologne appears in 55 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials55
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

55 shown
A Multicenter Phase II Trial to Evaluate Rechallenge With Platinum-based Chemotherapy (Carboplatin, Etoposide) for Progression During Tarlatamab Therapy in Relapsed Extensive Disease Small-cell Lung Cancer (SCLC)NCT07699237 · lead sponsor · 2026-11-01
NOT_YET_RECRUITING
Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin LymphomaNCT06919679 · lead sponsor · 2025-08-01
NOT_YET_RECRUITING
Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)NCT06419179 · lead sponsor · 2024-10-09
ENROLLING_BY_INVITATION
Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)NCT05818449 · lead sponsor · 2022-06-01
UNKNOWN
Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint InhibitorsNCT03989050 · lead sponsor · 2022-01-01
WITHDRAWN
Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced DiseaseNCT04630743 · lead sponsor · 2019-02-09
COMPLETED
Pre-operative Short-term Administration of a Formula Diet Containing a Non-milk-derived Protein Source for Prevention of Acute Kidney Injury After Cardiac SurgeryNCT03715868 · lead sponsor · 2019-01-15
COMPLETED
EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR MutationsNCT03516214 · lead sponsor · 2018-04-25
COMPLETED
Cognitive Behavioural Therapy for the Treatment of Late Life DepressionNCT03735576 · lead sponsor · 2017-10-01
COMPLETED
EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung CancerNCT02183870 · lead sponsor · 2014-05-01
COMPLETED
EP-Catheter Guided CS-Lead ImplantationNCT01922544 · lead sponsor · 2013-08-01
COMPLETED
Quantification of Drugs and Their Degradation ProductsNCT01828372 · lead sponsor · 2013-05-01
UNKNOWN
Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer PatientsNCT04635852 · lead sponsor · 2013-03-01
COMPLETED
Brief Title:Effect of a Preoperative Calorie Restriction on Renal Function After Cardiac SurgeryNCT01534364 · lead sponsor · 2012-01-01
COMPLETED
Clinical Intervention Psychosis and AddictionNCT01411566 · lead sponsor · 2011-01-01
UNKNOWN
Molecular Imaging With Erlotinib and BevacizumabNCT01047059 · lead sponsor · 2010-01-01
COMPLETED
Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's DiseaseNCT01094145 · lead sponsor · 2010-01-01
COMPLETED
The Influence of Anterior Chamber Fluid Mediators on the Success Rate of TrabeculectomyNCT01115218 · lead sponsor · 2009-10-01
COMPLETED
SORAVE - Sorafenib and Everolimus in Solid TumorsNCT00933777 · lead sponsor · 2009-07-01
COMPLETED
Trabeculectomy Versus Canaloplasty to Treat GlaucomaNCT00854256 · lead sponsor · 2009-04-01
UNKNOWN
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Incidence in Patients With Central Versus Peripheral EmbolismNCT01672203 · lead sponsor · 2009-01-01
UNKNOWN
Acute Hemodynamic Effects of Cocoa Polyphenols in Subjects With Hypertension and Optimal Blood PressureNCT00654862 · lead sponsor · 2007-10-01
COMPLETED
Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset PsychosisNCT00465920 · lead sponsor · 2007-05-01
UNKNOWN
A Clinical Trial on the Antipsychotic Properties of CannabidiolNCT00309413 · lead sponsor · 2006-03-01
COMPLETED
Effects of Cocoa Intake on Blood Pressure in Elderly Individuals With Mild HypertensionNCT00421499 · lead sponsor · 2005-01-01
COMPLETED
Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous LeukemiaNCT00152594 · lead sponsor · 2004-10-01
TERMINATED
Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute SchizophreniaNCT00637234 · lead sponsor · 2004-07-01
COMPLETED
Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic PsychosisNCT00628290 · lead sponsor · 2002-10-01
COMPLETED
Early Pharmacological and Psychological Intervention for Late Prodromal States of PsychosisNCT00204061 · lead sponsor · 2001-01-01
COMPLETED
Psychological Intervention for Persons in the Early Initial Prodromal StateNCT00204087 · lead sponsor · 2001-01-01
UNKNOWN
CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment RegimesNCT00966160 · lead sponsor · 1999-01-01
COMPLETED
Multidrug Resistance After Trabeculectomy With Mitomycin CNCT00449631 · lead sponsor
COMPLETED
Stratification and Treatment in Early Psychosis Study - ENHANCENCT06778564 · collaborator · 2026-09-01
RECRUITING
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early PsychosisNCT07645443 · collaborator · 2026-05-27
RECRUITING
Stratification and Treatment in Early Psychosis Study -ASSISTNCT07326124 · collaborator · 2026-06-01
NOT_YET_RECRUITING
Prevention-in-PD-StudyNCT07297407 · collaborator · 2026-04-01
NOT_YET_RECRUITING
Influence of Electronic Patient Reported Outcomes (ePROMs) in Surgical Therapy for Prostate Cancer on Postoperative OutcomeNCT05644821 · collaborator · 2023-08-01
COMPLETED
"HerzCheck" - Detection of Early Heart Failure Using Telemedicine in Structurally Weak RegionsNCT05122793 · collaborator · 2021-06-21
ACTIVE_NOT_RECRUITING
Automated Mechanical Peripheral Stimulation to Treat Freezing of Gait in Patients With Parkinson's Disease and STN-DBSNCT04831879 · collaborator · 2021-03-25
UNKNOWN
Early Diagnosis of SCD Based on RadiogenomicsNCT04696315 · collaborator · 2021-01-01
COMPLETED
Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple SclerosisNCT04233970 · collaborator · 2020-02-17
COMPLETED
Interactive Web Platform for EmPOWERment in Early Multiple SclerosisNCT03968172 · collaborator · 2019-07-01
COMPLETED
"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"NCT03149107 · collaborator · 2016-09-01
TERMINATED
Intracranial Pressure and Brain Function: Effects of Head Down Tilt Upon Brain Perfusion and Cognitive PerformanceNCT02976168 · collaborator · 2016-03-01
COMPLETED
Efficacy of ISST in SchizophreniaNCT02678858 · collaborator · 2016-03-01
COMPLETED
A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074NCT02511990 · collaborator · 2015-07-01
COMPLETED
Efficacy of Lifestyle Intervention in BRCA1/2 Mutation CarriersNCT02516540 · collaborator · 2015-03-01
UNKNOWN
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117NCT02018510 · collaborator · 2014-01-01
COMPLETED
Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction StudyNCT02051387 · collaborator · 2013-01-01
COMPLETED
Bupropion for the Treatment of Apathy in Alzheimer's DementiaNCT01047254 · collaborator · 2010-01-01
COMPLETED
Prevention Through Activity in Kindergarten TrialNCT00623844 · collaborator · 2007-05-01
COMPLETED
Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode SchizophreniaNCT00159120 · collaborator · 2001-11-01
COMPLETED
Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode SchizophreniaNCT00159133 · collaborator · 2001-11-01
COMPLETED
One Year Drug Treatment in First-Episode SchizophreniaNCT00159081 · collaborator · 2000-11-01
COMPLETED
Optimization of Acute Treatment in First Episode SchizophreniaNCT00157378 · collaborator · 2000-11-01
UNKNOWN

Drugs studied in this sponsor's trials

12 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Cologne as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
amisulpride3
cannabidiol2
crizotinib1
durvalumab1
fentanyl1
olanzapine1
olaparib1
oxcarbazepine1
amisulpride RxCUI 46303 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 3 trials cannabidiol RxCUI 2045371 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials crizotinib RxCUI 1148495 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial durvalumab RxCUI 1919503 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial fentanyl RxCUI 4337 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial olanzapine RxCUI 61381 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial olaparib RxCUI 1597582 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial oxcarbazepine RxCUI 32624 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial quetiapine RxCUI 51272 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial risperidone RxCUI 35636 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial trametinib RxCUI 1425099 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial voriconazole RxCUI 121243 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor32
collaborator23
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.